| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | OPHTHOTECH CORP | 35,649 | 1,644,000 | 0.01% | ||
| 102 | MYOKARDIA INC | 100,000 | 1,634,000 | 0.01% | ||
| 103 | SERES THERAPEUTICS INC | 125,000 | 1,536,000 | 0.01% | ||
| 104 | PALATIN TECHNOLOGIES INC COM | 2,050,000 | 1,289,000 | 0.01% | ||
| 105 | CELLECTIS S A | 50,000 | 1,204,000 | 0.01% | ||
| 106 | COLUCID PHARMACEUTICALS ORD | 30,310 | 1,156,000 | 0.01% | ||
| 107 | FULGENT GENETICS INC | 125,000 | 1,153,000 | 0.01% | ||
| 108 | IMMUNE DESIGN CORP | 148,937 | 1,129,000 | 0.01% | ||
| 109 | AFFIMED N V COM | 400,000 | 1,112,000 | 0.01% | ||
| 110 | Aldeyra Therapeutics Inc | 142,000 | 1,110,000 | 0.01% | ||
| 111 | ACCELERON PHARMA INC | 28,765 | 1,041,000 | 0.01% | ||
| 112 | FIVE PRIME THERAPEUTICS INC | 19,247 | 1,010,000 | 0.01% | ||
| 113 | TENAX THERAPEUTICS INC | 420,000 | 972,000 | 0.01% | ||
| 114 | MAST THERAPEUTICS INC COM | 8,584,051 | 944,000 | 0.01% | ||
| 115 | APTOSE BIOSCIENCES INC | 404,211 | 909,000 | 0.01% | ||
| 116 | INFINITY PHARMACEUTICALS INC | 580,400 | 905,000 | 0.01% | ||
| 117 | DYNAVAX TECHNOLOGIES CORP | 75,000 | 787,000 | 0.01% | ||
| 118 | ALNYLAM PHARMACEUTICALS INC | 11,340 | 769,000 | 0.01% | ||
| 119 | MADRIGAL PHARMACEUTICALS INC | 57,762 | 732,000 | 0.01% | ||
| 120 | ADAPTIMMUNE THERAPEUTICS PLC | 100,000 | 705,000 | 0.01% | ||
| 121 | RITTER PHARMACEUTICALS INC | 400,000 | 672,000 | 0.01% | ||
| 122 | WINDTREE THERAPEUTICS INC | 254,973 | 653,000 | 0.01% | ||
| 123 | CHIMERIX INC | 115,216 | 638,000 | 0.01% | ||
| 124 | ARBUTUS BIOPHARMA CORP | 180,582 | 621,000 | 0.01% | ||
| 125 | ABEONA THERAPEUTICS INC | 101,680 | 610,000 | 0.01% | ||
| 126 | BIODELIVERY SCIENCES INTL IN | 210,021 | 567,000 | 0.01% | ||
| 127 | Foundation Medicine | 20,892 | 488,000 | 0.00% | ||
| 128 | ACHAOGEN INC COM | 100,000 | 479,000 | 0.00% | ||
| 129 | CYTRX CORP | 659,995 | 388,000 | 0.00% | ||
| 130 | Sierra Oncology, Inc. | 200,000 | 364,000 | 0.00% | ||
| 131 | LA JOLLA PHARMACEUTICAL CO | 13,746 | 327,000 | 0.00% | ||
| 132 | CHEMOCENTRYX INC | 49,064 | 296,000 | 0.00% | ||
| 133 | CYCLACEL PHARMACEUTICALS INC | 13,253 | 90,000 | 0.00% | ||
| 134 | BIOTIME INC | 20,084 | 17,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-134352, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
